Yeah, and hey it might be that the drug does eventually turn out to a winner, who knows, I’ve been looking at this but will hold off for now. The whole cold to hot tumour story is more complex than appears here and many biotechs looking into that. The impression I get with the Nox drug is they’re trying a wee bit too hard to present it as offering a bit of everything like it’s magically active against all key targets. claims based on some usually unpublished bench top work and so far, not that much data.
just my opinion.
BMS woes continue, page-7
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23214 | 6.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 12000 | 1 |
View Market Depth
| Last trade - 16.12pm 02/07/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable